This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Poxel. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1,853 
1 out of 13 Years Active: 2015
Title: The Innovations of Xavier Leverve
Introduction
Xavier Leverve is a notable inventor based in La Terrasse, France. He has made significant contributions to the field of medical science, particularly in the treatment of ischemia and reperfusion-related diseases. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Xavier Leverve holds a patent for amino derivatives of dihydro-1,3,5-triazine, which are utilized in the treatment and prevention of diseases induced by ischemia and reperfusion. This invention is particularly relevant for addressing cardiac and renal complications, showcasing his commitment to advancing medical treatments. He has 1 patent to his name.
Career Highlights
Throughout his career, Xavier has worked with reputable organizations, including Poxel and the National Institute of Health and Medical Research. His experience in these institutions has allowed him to refine his expertise and contribute to groundbreaking research in his field.
Collaborations
Xavier has collaborated with esteemed colleagues such as Didier Mesangeau and Daniel Cravo. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Xavier Leverve's contributions to medical science through his innovative patent demonstrate his dedication to improving health outcomes. His work continues to inspire advancements in the treatment of ischemia and reperfusion-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile